Welcome to our dedicated page for Iveda Solutions SEC filings (Ticker: IVDAW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Iveda Solutions's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Iveda Solutions's regulatory disclosures and financial reporting.
Iveda Solutions, Inc. reported that Chief Executive Officer David H. Ly had his stock options repriced by the board. On February 23, 2026, options covering 175,000 shares were granted or awarded, and a separate 175,000-option position was disposed of back to the issuer. According to the disclosure, the repricing set the exercise price at $0.29 per share, while all other option terms remained unchanged. After these offsetting derivative transactions, Ly directly held options to acquire 216,096 shares.
Iveda Solutions director Joseph A. Farnsworth reported option transactions tied to an option repricing. On February 23, 2026, he acquired 100,000 stock options at an exercise price of $0.29 per share and disposed of 100,000 options back to the company, with other option terms remaining unchanged.
Iveda Solutions reporting persons Lind Global Fund III LP, Lind Global Partners III LLC and Jeff Easton disclose beneficial ownership of 1,158,920 shares, representing 9.99% of common stock as of 02/11/2026. The holdings consist of 857,143 shares of common stock and 1,714,286 warrants, but conversion of the warrants is contractually limited so the aggregate beneficial ownership has been capped at 1,158,920 shares.
The filing states that Lind Global Partners III LLC may be deemed to have sole voting and dispositive power for the partnership's shares and that Jeff Easton, as managing member, may be deemed to have sole voting and dispositive power. The filing includes a joint filing agreement and is signed on 02/19/2026.
Iveda Solutions, Inc. received a Schedule 13G reporting a significant but non-controlling position by Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC. As of the close of business on February 13, 2026, they may be deemed to beneficially own 592,195 shares of common stock issuable upon exercise of a warrant, representing about 4.99% of the outstanding common stock.
The filing explains that additional shares underlying several Intracoastal warrants are blocked from exercise if doing so would push ownership above limits of 4.99% or 9.99%. The reporting persons certify the securities were not acquired to change or influence control of Iveda.
Iveda Solutions, Inc. completed a public offering of 5,714,286 shares of common stock (or pre-funded warrants in lieu) and Series X warrants to purchase up to 11,428,572 shares at a combined price of $0.35. The transaction generated approximately $2 million in gross proceeds before fees and expenses. The company issued additional placement agent warrants and paid cash fees to H.C. Wainwright & Co. and plans to use the net proceeds for general corporate purposes, including potential R&D, debt repayment, working capital, capital spending, acquisitions, joint ventures, and stock repurchase programs. The offering was conducted under an effective Form S-1 registration statement.
Iveda Solutions, Inc. received an institutional ownership filing showing that entities affiliated with Iroquois Capital report meaningful positions in its common stock. Iroquois Capital Management LLC reports beneficial ownership of 500,000 shares, representing 4.5% of the common stock, with shared voting and dispositive power over these shares.
Richard Abbe reports beneficial ownership of 714,286 shares, or 6.4% of the class, combining 214,286 shares over which he has sole voting and dispositive power with 500,000 shares over which he shares authority. Kimberly Page reports beneficial ownership of 500,000 shares, or 4.5%, with shared voting and dispositive power.
The filing notes additional warrants held by related entities that are exercisable for up to 1,000,000 and 428,572 shares for certain funds, and 1,428,572 shares for Mr. Abbe, but these are currently blocked by 4.99% Beneficial Ownership Blockers. Based on a prospectus indicating 11,139,740 shares outstanding as of the completion of a recent offering, the reported percentages reflect these blockers. The reporting persons certify that the securities are not held for the purpose of changing or influencing control of Iveda Solutions.
Iveda Solutions, Inc. has filed an amended S-1 to offer up to 5,434,782 shares of common stock, together with up to 5,434,782 pre-funded warrants and up to 5,434,782 Series X warrants to buy up to 10,869,564 additional shares, on a reasonable best efforts basis. The assumed combined price is $0.92 per share and accompanying Series X warrants, matching the last Nasdaq Capital Market close on January 28, 2026.
The company, recently redomiciled to Delaware, develops AI-driven video analytics and IoT-based smart city platforms, with most revenue generated by its Taiwan subsidiary. It has a going concern opinion, accumulated losses of about $51 million through December 31, 2024, and relies heavily on a small number of key customers. There is no minimum offering amount or escrow, so investor funds become immediately available even if limited capital is raised, and the new securities will dilute existing holders, with common shares outstanding rising from 5,879,741 to 11,314,523 if all shares (but no warrants) are sold.
Iveda Solutions, Inc. is conducting a reasonable best efforts primary offering of up to 5,434,782 shares of common stock at an assumed combined price of $0.92 per share together with Series X warrants to purchase up to 10,869,564 additional shares. The company may instead issue up to 5,434,782 pre-funded warrants in lieu of common stock for investors constrained by 4.99% or 9.99% ownership limits, with each pre-funded warrant exercisable at $0.0001 per share.
The Series X warrants are exercisable upon issuance at $0.92 per share and expire two years after issuance. Common stock outstanding was 5,879,741 shares before the offering and is expected to be 11,314,523 shares after the offering, excluding existing options and warrants. Iveda highlights significant risks, including a going concern opinion, accumulated losses of roughly $51–53 million, heavy reliance on its Taiwan subsidiary for most revenue, customer concentration, and the possibility of Nasdaq delisting if listing standards are not maintained.
Iveda Solutions, Inc. reconvened its 2024 Annual Meeting of Stockholders on August 29, 2025, where stockholders approved the issuance of new common stock purchase warrants. A total of 1,409,415 shares entitled to vote, representing 58.5% of the company’s outstanding voting capital stock as of the October 7, 2024 record date, were present in person or by proxy, constituting a quorum.
Stockholders approved Proposal 5 to issue 625,000 Series A Common Stock Purchase Warrants and 625,000 Series B Common Stock Purchase Warrants, each with an exercise price of $3.44 per common share, along with the shares of common stock issuable upon exercise of these warrants. The proposal received 1,253,925 votes for, 121,349 votes against, and 34,141 abstentions.